#GioTag - Twitter Hashtag

about 4 years ago

@mangalpandeybjp मोदी सरकार के कदम से नहीं, मिथिला की जनता की एकता के वजह से मिला है ये #Giotag। आप लोगों ने तो इसे "बिहार मखाना" का टैग दिला कर ट्विटर ट्विटर भी खेल लिया था,, यादाश्त पर जोड़ डालिए महाराज । @MitjiL @MaithilAnup #mithilamakhaana

0

3

1

0

Oncology Central

@OncologyCentral

almost 5 years ago

Don't miss out on reading this Plain Language Summary of the #GioTag study on sequential #Afatinib + #Osimertinib in #EGFR #NSCLC https://t.co/wrhvmmxRzc #LCAM #lcsm #lungcancerawarenessmonth

OncologyCentral's tweet photo. Don't miss out on reading this Plain Language Summary of the #GioTag study on sequential #Afatinib + #Osimertinib in #EGFR #NSCLC https://t.co/wrhvmmxRzc #LCAM #lcsm #lungcancerawarenessmonth https://t.co/LWRx1ywuLA

0

2

1

0

Lung Cancer Europe

@LungCancerEu

over 5 years ago

Plain language summary of the final results from the #GioTag study. Read it here: https://t.co/Jw6XZ8qhe9 This study assessed how afatinib and osimertinib affected people with #NSCLC hosting #EGFR mutations.

LungCancerEu's tweet photo. Plain language summary of the final results from the #GioTag study.
Read it here: https://t.co/Jw6XZ8qhe9
This study assessed how afatinib and osimertinib affected people with #NSCLC hosting #EGFR mutations. https://t.co/pSyI6gLEb1

0

3

0

Oncology Central

@OncologyCentral

about 7 years ago

Watch this video abstract to find out more about research published by @fsgfon that presents an updated analysis of the observational #GioTag study. View the video and paper here: https://t.co/JkflzNYro3

OncologyCentral's tweet photo. Watch this video abstract to find out more about research published by @fsgfon that presents an updated analysis of the observational #GioTag study. View the video and paper here: https://t.co/JkflzNYro3 https://t.co/0OzEPkpRVv

0

5

3

0

PharmaPlatforms @pharmaplatforms

about 7 years ago

Discover more about the updated #GioTag publication with this #infographic #VisualAbstract

0

RegMedNet

@RegMedNet

about 7 years ago

Check out this great infographic highlighting updates from @Boehringer's #GioTag study, published in @fsgfon! #lungcancer

0

1

0

Boehringer Ingelheim

@BoehringerSA

about 7 years ago

#Prensa #CáncerdePulmón #Giotag

Boehringer Ingelheim @Boehringer

about 7 years ago

#PRESS: Updated real-world data from GioTag study shows median overall survival of almost four years in patients with EGFR Del19 and T790M mutation-positive NSCLC https://t.co/HpvjJYIouF